Do you suffer from Atrial Fibrillation?
Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots travelling through the blood stream to plug another vessel).
Atrial fibrillation is a condition of having irregular and often rapid heartbeat. It can lead to the formation of blood clots in the heart which can travel through the blood stream to plug another vessel, and like this lead to serious and life-threatening conditions, such as a stroke. A stroke occurs because the brain tissue beyond the blockage no longer receives nutrients and oxygen so that brain cells die. As strokes arising from atrial fibrillation can involve extensive areas of the brain, it is important to prevent them.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your condition to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others with this condition, and whether it will be made widely available to all patients in Canada. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Are 18 years of age or older
- Are medically stable and appropriate for chronic antithrombotic treatment
- Have been diagnosed with atrial fibrillation and are eligible to receive anticoagulation
- Must satisfy one or both of the following categories of risk factors (a or b):
- a) one or more of the following risk factors:
- i) age greater than or equal to 75 years
- ii) history of a clinical symptomatic stroke
- b) two or more of the following risk factors:
- i) age between 65 and 74 years
- ii) hypertension
- iii) diabetes mellitus
- iv) atherosclerotic vascular disease
- v) heart failure
- a) one or more of the following risk factors:
You may not qualify to participate if you:
- Have any hemodynamically significant valve disease, or valve disease that will potentially require surgical valve replacement during the study
- Have any condition other than atrial fibrillation that requires chronic anticoagulation
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.